DiaCarta Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 45
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 3

DiaCarta General Information

Description

Operator of translational genomics and personalized diagnostics company intended to provide treatments associated with precision molecular diagnostics. The company's technology focuses on genomic innovation through detection and amplification technologies and develops a range of cancer research and IVD products, specialized in genomic testing for biomarkers and offers clinical sample testing services, enabling healthcare practitioners to improve the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 2600 Hilltop Drive
  • Richmond, CA 94806
  • United States
+1 (800) 000-0000

DiaCarta Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DiaCarta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - PPP 14-May-2020 0000 Completed Generating Revenue
2. Later Stage VC (Series B) 12-Feb-2018 0000 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 09-Jan-2015 $8M $8M Completed Product Development
To view DiaCarta’s complete valuation and funding history, request access »

DiaCarta Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of translational genomics and personalized diagnostics company intended to provide treatments associated with p
Biotechnology
Richmond, CA
45 As of 2021
0000
000000000 - 0000

000000 0

m ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000

00000000

iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000000000000
Davis, CA
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DiaCarta Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CRISPR Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
0000000000 0000000 Corporation Davis, CA 000000000 -
00000000 0000 0000 Formerly VC-backed Newark, CA 000 000.00 000000&0 000.00
0000000 00000000 Venture Capital-Backed Milpitas, CA 00 000.00 0000000000 000.00
00000000 Corporation Alameda, CA 00 000000000 -
You’re viewing 5 of 36 competitors. Get the full list »

DiaCarta Patents

DiaCarta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2010356288-B2 Methods and kits for detecting an infectious agent Active 30-Jun-2010 000000000
AU-2017210617-A1 Methods and kits for detecting an infectious agent Abandoned 30-Jun-2010 000000000
AU-2010356288-A1 Methods and kits for detecting an infectious agent Granted 30-Jun-2010 000000000
GB-201223247-D0 Methods and kits for detecting an infectious agent Withdrawn 30-Jun-2010 000000000
GB-2494093-A Methods and kits for detecting an infectious agent Withdrawn 30-Jun-2010 C12Q1/689
To view DiaCarta’s complete patent history, request access »

DiaCarta Executive Team (8)

Name Title Board Seat Contact Info
Aiguo Zhang Ph.D Co-Founder, President & Chief Executive Officer
Michael Sha Ph.D Chief Technology Officer & Senior Vice President of Research & Development
Michael Powell Ph.D Chief Scientific Officer
Cynthia Virata Director of QA and Operations
Richard Brand Chief Financial Officer
You’re viewing 5 of 8 executive team members. Get the full list »

DiaCarta Board Members (1)

Name Representing Role Since
Weixin Xu Ph.D BVCF Board Member 000 0000
To view DiaCarta’s complete board members history, request access »

DiaCarta Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DiaCarta Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fortune Fountain Capital PE/Buyout Minority 000 0000 000000 0
Global Healthcare Capital Real Estate Minority 000 0000 000000 0
BVCF Venture Capital Minority 000 0000 000000 0
To view DiaCarta’s complete investors history, request access »